Nephrogenic fibrosing dermopathy: Difference between revisions
No edit summary |
No edit summary |
||
| Line 21: | Line 21: | ||
==[[Nephrogenic fibrosing dermopathy risk factors|Risk Factors]]== | ==[[Nephrogenic fibrosing dermopathy risk factors|Risk Factors]]== | ||
==[[Nephrogenic fibrosing dermopathy natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ==[[Nephrogenic fibrosing dermopathy natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
| Line 28: | Line 26: | ||
==Diagnosis== | ==Diagnosis== | ||
[[Nephrogenic fibrosing dermopathy history and symptoms|History and Symptoms ]] | [[ Nephrogenic fibrosing dermopathy physical examination|Physical Examination]] | [[Nephrogenic fibrosing dermopathy laboratory findings|Laboratory Findings]] | [[Nephrogenic fibrosing dermopathy x ray|X-Ray]] | [[Nephrogenic fibrosing dermopathy CT|CT]] | [[Nephrogenic fibrosing dermopathy MRI|MRI]] | [[Nephrogenic fibrosing dermopathy | [[Nephrogenic fibrosing dermopathy history and symptoms|History and Symptoms ]] | [[ Nephrogenic fibrosing dermopathy physical examination|Physical Examination]] | [[Nephrogenic fibrosing dermopathy laboratory findings|Laboratory Findings]] | [[Nephrogenic fibrosing dermopathy x ray|X-Ray]] | [[Nephrogenic fibrosing dermopathy CT|CT]] | [[Nephrogenic fibrosing dermopathy MRI|MRI]] | [[Nephrogenic fibrosing dermopathy ultrasound|Ultrasound]] | [[Nephrogenic fibrosing dermopathy other imaging findings|Other Imaging Findings]] | [[Nephrogenic fibrosing dermopathy other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
[[Nephrogenic fibrosing dermopathy medical therapy|Medical Therapy]] | [[Nephrogenic fibrosing dermopathy surgery |Surgery | [[Nephrogenic fibrosing dermopathy medical therapy|Medical Therapy]] | [[Nephrogenic fibrosing dermopathy surgery |Surgery]] | [[Nephrogenic fibrosing dermopathy secondary prevention|Secondary Prevention]] | [[Nephrogenic fibrosing dermopathy cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Nephrogenic fibrosing dermopathy future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
Latest revision as of 15:18, 28 September 2012
|
Nephrogenic fibrosing dermopathy Microchapters |
|
Differentiating Nephrogenic fibrosing dermopathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Nephrogenic fibrosing dermopathy On the Web |
|
American Roentgen Ray Society Images of Nephrogenic fibrosing dermopathy |
|
Directions to Hospitals Treating Nephrogenic fibrosing dermopathy |
|
Risk calculators and risk factors for Nephrogenic fibrosing dermopathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Assistant Editor-in-Chief: Brian Blank
Synonyms and keywords: nephrogenic systemic fibrosis
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Nephrogenic fibrosing dermopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | X-Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Source